An illumination device 1, 10, 100, 1, 1 for ear surgery, said illumination device 1, 10, 100, 1, 1 comprising a body 20, 200, 2000, 20, 20 having a first end 20a, 200a, 2000a, 20a, 20a and a second end 20b, 200b, 2000b, 20b, 20b; a light source 22,220,2200, 22, 22 provided at the second end 20b, 200b, 2000b, 20b, 20b; and means 30, 300, 3000, 30, 30 for supporting said body 20, 200, 2000, 20, 20 and said light source 22, 220, 2200, 22, 22 in a patient's ear canal.

A device, including a therapeutics substance delivery apparatus and an incisor, wherein the device is a minimally invasive inner ear therapeutic substance delivery device configured to reach the inner ear through a passage through the tympanic membrane to incise through tissue and deliver a therapeutic substance, and the incisor is at least one of a drill bit configured to drill through a promontory of a cochlea of a human, or a conduit configured to pierce a round window of the human with a fully intact round window niche.

A device, including a therapeutics substance delivery apparatus and an incisor, wherein the device is a minimally invasive inner ear therapeutic substance delivery device configured to reach the inner ear through a passage through the tympanic membrane to incise through tissue and deliver a therapeutic substance, and the incisor is at least one of a drill bit configured to drill through a promontory of a cochlea of a human, or a conduit configured to pierce a round window of the human with a fully intact round window niche.

The technology involves scaffold structures used for in-ear sensor systems. Such systems that can perform biometric signal detection or act as a human-computer interface. Scaffolding arrangements minimize the amount of material placed in the ear while providing a secure fitting device that can be worn for hours, days or longer in order to provide maximal benefit to the wearer. The scaffolding includes a C-shaped arcuate curvature for at least part of the housing. This configuration can act as a natural leaf spring to help maintain the housing in contact with different points along the ear. Sensors are located along various points of the scaffolding for use in different diagnostic situations. Different components of an on-board sensor input and processing system can be distributed along different parts of the scaffolding. Such structures beneficially minimize ambient sound occlusion and avoid the need of an exterior strap or clip worn around the ear.

The technology involves scaffold structures used for in-ear sensor systems. Such systems that can perform biometric signal detection or act as a human-computer interface. Scaffolding arrangements minimize the amount of material placed in the ear while providing a secure fitting device that can be worn for hours, days or longer in order to provide maximal benefit to the wearer. The scaffolding includes a C-shaped arcuate curvature for at least part of the housing. This configuration can act as a natural leaf spring to help maintain the housing in contact with different points along the ear. Sensors are located along various points of the scaffolding for use in different diagnostic situations. Different components of an on-board sensor input and processing system can be distributed along different parts of the scaffolding. Such structures beneficially minimize ambient sound occlusion and avoid the need of an exterior strap or clip worn around the ear.

A method and system of treating connective tissue to increase flexibility of the connective tissue or decrease tension in the connective tissue includes forming perforations in the connective tissue to at least 90% of the depth or thickness of the connective tissue and maintaining the perforations in the connective tissue. The method alters the tissue to enhance the fundamental mechanisms involved the immunology, biochemistry, and molecular genetics of the metabolism of the connective tissue.

A method and system of treating connective tissue to increase flexibility of the connective tissue or decrease tension in the connective tissue includes forming perforations in the connective tissue to at least 90% of the depth or thickness of the connective tissue and maintaining the perforations in the connective tissue. The method alters the tissue to enhance the fundamental mechanisms involved the immunology, biochemistry, and molecular genetics of the metabolism of the connective tissue.

Sinusitis and other disorders of the ear, nose and throat are diagnosed and/or treated using minimally invasive approaches with flexible or rigid instruments. Various methods and devices are used for remodeling or changing the shape, size or configuration of a sinus ostium or duct or other anatomical structure in the ear, nose or throat; implanting a device, cells or tissues; removing matter from the ear, nose or throat; delivering diagnostic or therapeutic substances or performing other diagnostic or therapeutic procedures. Introducing devices (e.g., guide catheters, tubes, guidewires, elongate probes, other elongate members) may be used to facilitate insertion of working devices (e.g. catheters e.g. balloon catheters, guidewires, tissue cutting or remodeling devices, devices for implanting elements like stents, electrosurgical devices, energy emitting devices, devices for delivering diagnostic or therapeutic agents, substance delivery implants, scopes etc.) into the paranasal sinuses or other structures in the ear, nose or throat.

Substance delivering spacer devices may comprise expandable reservoirs that are implantable in paranasal sinuses and other cavities, openings and passageways of the body to maintain patency and to provide sustained local delivery of a therapeutic or diagnostic substance. Delivery apparatus including elongate tubular members as well as shapeable distal portions and atraumatic tips are provided. Also provided are sinus penetrator devices and systems for performing ethmoidotomy procedures or for creating other openings in the walls of paranasal sinuses or other anatomical structures.

Systems and methods are provided for anesthetizing a tympanic membrane of an ear. The systems are personalizable to ensure proper anesthetizing solution administration. The systems and methods may also be useful for administering a solution to the ear canal of a human patient and for maintaining the solution therein.